UAE and Bahrain to Offer Third Sinopharm Shot

The United Arab Emirates and Bahrain have announced that they will offer a third dose of the Sinopharm Covid-19 vaccine, at least six months after receiving the first two doses. 

“As part of the UAE’s proactive strategy to provide maximum protection for society, an additional supportive dose of Sinopharm is now available for people who have received the vaccine previously and who have completed more than 6 months since the second dose,” in a statement by the National Emergency Crisis and Disasters Management Authority on Tuesday. 

The UAE will prioritize senior citizens and individuals with chronic diseases. 

Meanwhile, The National Medical Taskforce for Combatting the Coronavirus in Bahrain said that it will offer a booster for “the most vulnerable groups in Bahrain, at least 6 months after taking the second dose of the Sinopharm vaccine,” official Bahrain News Agency reported.

The booster distribution will also prioritize frontline workers, individuals above the age of 50 as well as those suffering with underlying health conditions. 

Both countries have also approved vaccination for the age group between 12-15 for the UAE and 12-17 for Bahrain with the Pfizer-BioNTech vaccine.

© Fourth Estate® — All Rights Reserved.
This material may not be published, broadcast, rewritten or redistributed.